Methotrexate is Not an Additional Risk Factor for Interstitial Lung Disease in RA Patients
8 Jul, 2020 | 00:54h | UTCRelated Review: Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows – Journal of Clinical Medicine